RecruitingNCT05534347
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
Angiogenic Inflammatory Biomarkers in Juvenile Idiopathic Arthritis
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
300 participants
Start Date
Mar 13, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of the study is to determine whether serum inflammatory angiogenic markers (eg, semaphorins, CCN1) predict severity of juvenile idiopathic arthritis defined by structural progression and/or therapeutic escalation.
Eligibility
Min Age: 16 Years
Inclusion Criteria5
- Greater than or equal to 16 years-old
- Diagnosis of Juvenile Idiopathic Arthritis with specialized follow up in Rheumatology at Cochin Hospital
- No-opposition to the research
- Patient with health insurance
- Mastery of the French language
Exclusion Criteria2
- Patient under curatorship or guardianship
- Patient receiving french state medical aid
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BIOLOGICALBlood sample
Addtional tube of blood needed for follow up of patients
BIOLOGICALJoint puncture
Joint puncture if needed according to routine care of the patients
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05534347
Related Trials
OLE Study With Filgotinib in JIA
NCT075531824 locations
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
NCT070879122 locations
Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis
NCT072347471 location
Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients
NCT071857501 location
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
NCT070657471 location